@TheRealKingRosa@TimHailstone@IanCopeland5@joerogan It’s a common misconception, but developing a cure for a disease is more profitable than providing ongoing treatment. A good recent example was the development of Sovaldi, which cures 90%+ of Hep C cases. Gilead made boatloads and buried the competition.